PharmiWeb.com - Global Pharma News & Resources
20-Apr-2019

Active Pharmaceutical Ingredient (API) Market is Anticipated to Surpass USD 260 Billion up to 2026

Recent study titled, Active Pharmaceutical Ingredient (API) Market Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026which covers detailed statistical analysis and enlightens market dynamics and trends that provide a holistic picture of the industry.

TheActive Pharmaceutical Ingredient (API) MarketIndustry Report 2018is anin depthstudy analyzing the current state of theActive Pharmaceutical Ingredient (API) Market. It providesbriefoverview of the market focusing on definitions, market segmentation, end-use applicationsandindustry chain analysis. The study on Active Pharmaceutical Ingredient (API) Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition,reportalso provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Active Pharmaceutical Ingredient (API) Market also discusses the opportunity areas for investors.

Download Sample Copy of this Report@ https://www.acumenresearchandconsulting.com/request-sample/146

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Market Players:

The Active Pharmaceutical Ingredient (API) market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are AbbVie Inc.; Merck amp; Co., Inc.; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries Ltd; Cipla, Inc.; Albemarle Corporation; Bristol-Myers Squibb Company; Sun Pharmaceutical Industries Ltd.; Mylan N.V.; Aurobindo Pharma; and Dr. Reddyrsquo;s Laboratories Ltd.

The Major Market Segments of GlobalActive Pharmaceutical Ingredient (API) Marketare as below:

Market Segmentation

Active Pharmaceutical Ingredient (API) Industry, by Type of Synthesis

  • Biotech
    • Monoclonal antibodies
    • Recombinant proteins
    • Vaccines
  • Synthetic

Active Pharmaceutical Ingredient (API) Market, by Type of Manufacturer

  • Captive APIs
  • Merchant APIs

Active Pharmaceutical Ingredient (API) Market, by Type

  • Innovative APIs
  • Generic APIs

Active Pharmaceutical Ingredient (API) Market, by Application

  • Cardiology
    • Generic
    • Innovative
  • Orthopedic
    • Generic
    • Innovative
  • Oncology
    • Generic
    • Innovative
  • Endocrinology
    • Generic
    • Innovative
  • Pulmonology
    • Generic
    • Innovative
  • Gastroenterology
    • Generic
    • Innovative
  • CNS amp; Neurology
    • Generic
    • Innovative
  • Nephrology
    • Generic
    • Innovative
  • Ophthalmology
    • Generic
    • Innovative
  • Others

Global Active Pharmaceutical Ingredient (API) Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on ldquo;Active Pharmaceutical Ingredient (API) Market (By Type of Synthesis: Biotech [Monoclonal antibodies, Recombinant proteins, Vaccines], Synthetic; By Type of Manufacturer: Captive APIs, Merchant APIs; By Type: Innovative APIs, Generic APIs; By Application: Cardiology [Generic, Innovative], Orthopedic [Generic, Innovative], Oncology [Generic, Innovative], Endocrinology [Generic, Innovative], Pulmonology [Generic, Innovative], Gastroenterology [Generic, Innovative], CNS amp; Neurology[Generic, Innovative], Nephrology [Generic, Innovative], Ophthalmology [Generic, Innovative], Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026rdquo; offers detailed insights on global Active Pharmaceutical Ingredient (API) market segments with market dynamics and their impact. The report provides insights on global Active Pharmaceutical Ingredient (API) market by type of synthesis, type of manufacturer, type, application, and major geographic regions. The report also covers basic technology development policies.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

CHAPTER 4. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE OF SYNTHESIS

CHAPTER 5. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE OF MANUFACTURER

CHAPTER 6. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE

CHAPTER 7. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY APPLICATION

CHAPTER 8. NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY

CHAPTER 9. EUROPE ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY

CHAPTER 10. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY

CHAPTER 11. LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY

CHAPTER 12. MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY

CHAPTER 13. AFRICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY

CHAPTER 14. COMPANY PROFILE

CHAPTER 15. RESEARCH APPROACH

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/146

Editor Details

Last Updated: 20-Apr-2019